Ana Rita Gigante

Mrs. Ana Rita Gigante

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2021 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
AAAdelaide Alves
Adelaide Alves
AGAna Rita Gigante
Ana Rita Gigante
DMDaniela Machado
Daniela Machado
ISInês Sanches
Inês Sanches
RMRaquel Marçoa
Raquel Marçoa
DFDaniela Ferreira
Daniela Ferreira
Objective: Obstructive sleep apnea (OSA) is a common disorder associated with a significant economic burden. Continuous positive airway pressure (CPAP) and auto-titrating positive airway pressure (APAP) are recognized therapeutic options in patients with OSA, although treatment costs are higher with APAP. We conducted a study aimed at evaluating the effectiveness and potential cost savings resulting from the implementation of a protocol guiding the transition to CPAP in OSA patients previously treated with APAP. Methods: This prospective study included patients with OSA under APAP who were followed up at the Sleep Medicine outpatient clinic of a tertiary referral hospital between January 2019 and January 2021. Treatment was switched to CPAP in patients who met the following criteria: satisfactory adaptation and adherence to APAP, residual apnea-hypopnea index (AHI) of < 5/hour, and no relevant air leaks. APAP and CPAP outcomes were compared and an estimate of the savings obtained by the transition from APAP to CPAP was calculated. Results: Ninety-three patients were included in the study. APAP and CPAP were both effective in correcting obstructive events and improving daytime sleepiness. No significant differences were found regarding treatment adherence and tolerance between both PAP modalities. The selection of fixed-pressure CPAP through 90th or 95th percentile APAP pressure proved to be effective and an alternative strategy to titration polysomnography. At the end of this two-year study, the transition from APAP to CPAP enabled savings of at least 10,353?. Conclusion: The transition from APAP to CPAP may be an effective, well-tolerated, safe, and cost-saving strategy in patients with OSA.

21 February 2023 in Genes
Verified
Journal Article
Open access
PDF file
ETEduarda Milheiro Tinoco
Eduarda Milheiro Tinoco
AGAna Rita Gigante
Ana Rita Gigante
EFEdite Ferreira
Edite Ferreira
ISInês Sanches
Inês Sanches
RPRute Pereira
Rute Pereira
IPIvone Pascoal
Ivone Pascoal
Primary ciliary dyskinesia (PCD) is a rare hereditary condition characterized by decreased mucociliary clearance of the airways and a compromised reproductive system, resulting in male and female infertility. Several mutations with varied clinical and pathological features have been documented, making diagnosis a challenging process. The purpose of this study is to describe the clinical and pathological features of Portuguese patients with PCD and to examine their genetic variants. A retrospective observational analysis was conducted with patients who were being monitored at a bronchiectasis outpatient clinic in 2022 and had a confirmed or high-likelihood diagnosis of PCD. In total, 17 patients were included in the study, with 12 (66.7%) having PCD confirmed and 5 (29.4%) having a high-likelihood diagnosis. Furthermore, 12 patients were subjected to transmission electron microscopy (TEM), with 7 (58.3%) exhibiting one hallmark defect. Genetic test data was obtained for all 17 patients, with 7 of them (41.2%) displaying a pathogenic/likely pathogenic mutation in homozygosity. To summarize, PCD is an uncommon but significant hereditary illness with consequences regarding morbidity and mortality. Despite the lack of a specific treatment, it is critical to confirm the diagnosis with genetic testing in order to effectively manage the disease and its accompanying disorders.

24 June 2022 in Respiratory Medicine and Research
Verified
Journal Article
Closed access
AGAna Rita Gigante
Ana Rita Gigante
ETEduarda Milheiro Tinoco
Eduarda Milheiro Tinoco
CNCarla Nogueira
Carla Nogueira
SCSara Conde
Sara Conde
CRCarla Ribeiro
Carla Ribeiro

27 January 2023 in Genes
Verified
Journal Article
Open access
PDF file
AGAna Rita Gigante
Ana Rita Gigante
ETEduarda Milheiro Tinoco
Eduarda Milheiro Tinoco
AFAna Fonseca
Ana Fonseca
IMInês Marques
Inês Marques
ASAgostinho Sanches
Agostinho Sanches
SNSofia Neves
Sofia Neves
Familial interstitial pneumonia (FIP) is defined as idiopathic interstitial lung disease (ILD) in two or more relatives. Genetic studies on familial ILD discovered variants in several genes or associations with genetic polymorphisms. The aim of this study was to describe the clinical features of patients with suspected FIP and to analyze the genetic variants detected through next-generation sequencing (NGS) genetic testing. A retrospective analysis was conducted in patients followed in an ILD outpatient clinic who had ILD and a family history of ILD in at least one first- or second-degree relative and who underwent NGS between 2017 and 2021. Only patients with at least one genetic variant were included. Genetic testing was performed on 20 patients; of these, 13 patients had a variant in at least one gene with a known association with familial ILD. Variants in genes implicated in telomere and surfactant homeostasis and MUC5B variants were detected. Most variants were classified with uncertain clinical significance. Probable usual interstitial pneumonia radiological and histological patterns were the most frequently identified. The most prevalent phenotype was idiopathic pulmonary fibrosis. Pulmonologists should be aware of familial forms of ILD and genetic diagnosis.

30 May 2023 in Pulmonology
Verified
Journal Article
Open access
AGAna Rita Gigante
Ana Rita Gigante
ETEduarda Milheiro Tinoco
Eduarda Milheiro Tinoco
IMI. Marques
I. Marques
ESE. Silva
E. Silva
TST. Shiang
T. Shiang
TPT. Pereira
T. Pereira

5 September 2021 in European Respiratory Journal
Verified
Conference Paper
Closed access
AGAna Rita Gigante
Ana Rita Gigante
MSMargarida Sousa
Margarida Sousa
AAAna Aguiar
Ana Aguiar
MPMarta Pinto
Marta Pinto
RGRita Gaio
Rita Gaio
RDRaquel Duarte
Raquel Duarte
Background: There’s a critical need for evidence on possible links between COVID-19 and Pulmonary tuberculosis (PTB) control. Eventual negative impacts of the pandemic urge to be precociously recognized and addressed to mitigate its present and future consequences. Aims: To assess COVID-19 possible effects on PTB control. Methods: This is a retrospective study of patients followed in a Portuguese TB outpatient centre between March-December 2019 (pre-pandemic [PP]) and in the same period of 2020 (pandemic [PD]). Demographic and clinical features, time from the onset of the first symptom until diagnosis (SD) and from diagnosis to treatment initiation (DT) were compared. Index patients with positive respiratory samples smear or culture and all contacts screened by index case were included. Cohabitation, contact sphere, and screening results were also considered. Results: Among 40 index patients with PTB in 2019 PP and 27 in 2020 PD, SD median[IQR] time was 43 [15.5-75] vs 34 [18-77] days (p=0.980) respectively; DT median time was 0 [0-1] vs 1 [0-2] days (p=0.014). A median of 7 [3.5-12.5] vs 8 [4-14] (p=0.505) contacts were screened by index case, with a median positivity rate of 8 [0-14] vs 20 [7-45]% (p=0.007). Among positive contacts, 21.2% vs 38.9% (p=0.024) were household-type. Latent TB infection was diagnosis in 87.9% vs 93.1% positive contacts and TB disease was found in 12.1% vs 6.9% (p=0.298). Conclusions: COVID-19 pandemic seems to have had an impact in: decreased new cases of PTB; slight delay in treatment initiation; increased screening rate of positive contacts and household transmission.